金彩汇

    news & event about long-acting interferon drug product company
    Home / News / Company News / Donation Agreement for "Clinical Cure (Everest) Project of CHB in China" is signed in Beijing

    Donation Agreement for "Clinical Cure (Everest) Project of CHB in China" is signed in Beijing

    Views: 0     Author: Site Editor     Publish Time: 2017-12-31      Origin: Site

    Inquire

    facebook sharing button
    twitter sharing button
    line sharing button
    wechat sharing button
    linkedin sharing button
    pinterest sharing button
    whatsapp sharing button
    sharethis sharing button

           为有助于中国专家已取得的乙肝临床治愈研究成果,持续探索、优化、完善临床治愈路径,造福更多慢乙肝患者,实现临床治愈梦想。由中国肝炎防治基金会发起设立的“中国慢乙肝临床治愈(珠峰)工程”公益项目于12月29日在北京签约。中国肝炎防治基金会常务副理事长兼秘书长杨希忠、厦门金彩汇生物工程股份有限公司总经理孙黎分别代表甲、乙方签署协议,双方相关人员参加了签约仪式。



    签约仪式现场



    该项目旨在汇聚中国专家智慧,共攀乙肝治愈高峰,提高各级医生乙肝诊疗水平,提升患者对乙肝治疗的认知。计划在全国上百家医院召开慢乙肝临床治愈工作、培养千名临床医生、临床治愈万名慢乙肝患者,为落实《中国病毒性肝炎防治规划》(2017-2020),实现《“健康中国2030”规划纲要》和WHO提出2030年消除肝炎目标做出贡献。



    签约仪式现场



    文章来源:中国肝炎防治基金会


    RELATED NEWS

    content is empty!

    RELATED PRODUCTS

    content is empty!

    Facebook
    Twitter
    LinkedIn
    Instagram

    WELCOME

    Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
    Leave a Message
    Get In Touch